onsemi is putting a higher number on Synaptics: $123 per share in cash under a revised merger agreement. The transaction links two Nasdaq-listed semiconductor companies in a deal the companies say is immediately accretive to onsemi’s earnings per share.

For shareholders, the revised terms sharpen both sides of the equation. Synaptics investors are evaluating a defined cash consideration, while onsemi shareholders are being asked to assess whether the strategic combination can deliver the promised EPS benefit after closing. The price is clear; the execution path is not.

onsemi, which trades as Nasdaq: $ON, agreed to acquire Synaptics, Nasdaq: $SYNA, under the revised all-cash arrangement. The companies describe the updated terms as intended to deliver greater value to onsemi shareholders, while also emphasizing immediate earnings-per-share accretion.

What the $123 offer changes

The central market fact is the revised $123-per-share cash consideration. Unlike a stock-based transaction, an all-cash structure gives Synaptics investors a specified dollar amount rather than exposure to movements in onsemi’s share price as merger consideration. That makes the offer easier to evaluate in headline terms, although the final outcome still depends on the transaction closing.

For onsemi shareholders, the key argument is not simply the acquisition price. It is the companies’ claim that the deal is immediately accretive to EPS. If that rationale holds after completion, the transaction could add to reported per-share earnings from the outset rather than requiring a lengthy integration period before an earnings contribution emerges. The supplied announcement does not provide an EPS percentage, financial projections or valuation multiple, so investors will need to focus on the terms actually disclosed.

Three variables investors will monitor

• Deal-close timing: The schedule matters because the claimed EPS benefit cannot be realized through the combined company until the transaction closes.
• Financing terms: The consideration is all cash, making the funding structure an important part of the shareholder analysis. The supplied details do not specify the financing mix or associated cost.
• Regulatory review: Required review could affect the timetable and the certainty of completion. No specific regulator, condition or review outcome is identified in the supplied information.

Those variables create the gap between an announced transaction and a completed one. The $123 price provides a concrete reference point, while the immediate EPS-accretion claim provides onsemi shareholders with the principal financial rationale. Neither removes the need to monitor execution.

A broader semiconductor signal

The revised agreement also arrives as a market signal for Nasdaq-listed semiconductor companies. Based on the supplied context, the transaction may indicate renewed M&A activity and consolidation pressure in the sector. A higher cash offer suggests that strategic combinations remain a live tool for pursuing scale and earnings impact, even as investors weigh financing and regulatory constraints.

The cleanest read-through is therefore mixed: Synaptics has a revised $123-per-share cash proposal, and onsemi has an immediate EPS-accretion thesis. The market’s next questions are operational—when the deal closes, how the cash is financed and whether regulatory review changes the path.

The companies’ revised merger announcement provides the primary reference for the $123 cash terms and the stated EPS rationale. Additional coverage is available from Seeking Alpha.